Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older

By Levine M.J.   Ellison M.C.   Zerbe G.O.   Barber D.   Chan C.   Stinson D.   Jones M.   Hayward A.R.  

Vaccine, Vol. 18, Iss. 25, 2000-06 ,pp. : 2915-2920

Elsevier

Access to resources Recommend Favorite

Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay

By Takahashi M.   Okada S.   Miyagawa H.   Amo K.   Yoshikawa K.   Asada H.   Kamiya H.   Torigoe S.   Asano Y.   Ozaki T.   Terada K.   Muraki R.   Higa K.   Iwasaki H.   Akiyama M.   Takamizawa A.   Shiraki K.   Yanagi K.   Yamanishi K.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3845-3853

Elsevier

Access to resources Recommend Favorite

Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial

By Trannoy E.   Berger R.   Hollander G.   Bailleux F.   Heimendinger P.   Vuillier D.   Creusvaux H.  

Vaccine, Vol. 18, Iss. 16, 2000-02 ,pp. : 1700-1706

Elsevier

Access to resources Recommend Favorite

Induction of neutralizing antibody and T-cell responses to Varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE)

By Garcia-Valcarcel M.   Fowler W.J.   Harper D.R.   Jeffries D.J.   Layton G.T.  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 709-719

Elsevier

Access to resources Recommend Favorite

Comparison of gpELISA and neutralizing antibody responses to Oka/Merck live varicella vaccine (Varivax(R)) in children and adults

By Krah D.L.   Cho I.   Schofield T.   Ellis R.W.  

Vaccine, Vol. 15, Iss. 1, 1997-01 ,pp. : 61-64

Elsevier

Access to resources Recommend Favorite